These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 18660719

  • 1. Cytotoxic treatment-induced gastrointestinal symptoms.
    Blijlevens NM.
    Curr Opin Support Palliat Care; 2007 Apr; 1(1):16-22. PubMed ID: 18660719
    [Abstract] [Full Text] [Related]

  • 2. Implications of treatment-induced mucosal barrier injury.
    Blijlevens NM.
    Curr Opin Oncol; 2005 Nov; 17(6):605-10. PubMed ID: 16224241
    [Abstract] [Full Text] [Related]

  • 3. Aprepitant--where do we stand in the control of chemotherapy-induced nausea and vomiting?
    Sarcev T, Secen N, Zaric B, Milovancev A.
    J BUON; 2008 Nov; 13(3):333-9. PubMed ID: 18979546
    [Abstract] [Full Text] [Related]

  • 4. Aprepitant (EMEND): the role of substance P in nausea and vomiting.
    Prommer E.
    J Pain Palliat Care Pharmacother; 2005 Nov; 19(3):31-9. PubMed ID: 16219609
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Chemotherapy-induced nausea and vomiting.
    Lohr L.
    Cancer J; 2008 Nov; 14(2):85-93. PubMed ID: 18391612
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Chemotherapy-induced nausea and vomiting: clinician and patient perspectives.
    Schwartzberg LS.
    J Support Oncol; 2007 Feb; 5(2 Suppl 1):5-12. PubMed ID: 17366928
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Chemotherapy-induced nausea and vomiting in the treatment of gastrointestinal tumors and secondary prophylaxis with aprepitant.
    Abbrederis K, Lorenzen S, Rothling N, Ihbe-Heffinger A, Schuster T, Peschel C, Lordick F.
    Onkologie; 2009 Feb; 32(1-2):30-4. PubMed ID: 19209016
    [Abstract] [Full Text] [Related]

  • 13. Update on the management of chemotherapy-related nausea and vomiting: an emphasis on the new class of agents--neurokinin-1 receptor antagonists.
    Gralla R.
    Clin Adv Hematol Oncol; 2006 Jul; 4(7):507-8. PubMed ID: 17147235
    [No Abstract] [Full Text] [Related]

  • 14. [Management of emesis in cancer patients].
    Slimane K, Perez A, Ruffié P, di Palma M.
    Bull Cancer; 2004 May; 91(5):403-8. PubMed ID: 15281279
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting: beyond prevention of acute emesis.
    Slatkin NE.
    J Support Oncol; 2007 May; 5(5 Suppl 3):1-9. PubMed ID: 17566383
    [Abstract] [Full Text] [Related]

  • 17. New drug helps relieve chemotherapy-related symptoms.
    FDA Consum; 2003 May; 37(4):3. PubMed ID: 12971326
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.